» Articles » PMID: 36277484

The Role of Ubiquitination in Spinal and Bulbar Muscular Atrophy

Overview
Specialty Molecular Biology
Date 2022 Oct 24
PMID 36277484
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal and bulbar muscular atrophy (SBMA) is a neurodegenerative and neuromuscular genetic disease caused by the expansion of a polyglutamine-encoding CAG tract in the androgen receptor (AR) gene. The AR is an important transcriptional regulator of the nuclear hormone receptor superfamily; its levels are regulated in many ways including by ubiquitin-dependent degradation. Ubiquitination is a post-translational modification (PTM) which plays a key role in both AR transcriptional activity and its degradation. Moreover, the ubiquitin-proteasome system (UPS) is a fundamental component of cellular functioning and has been implicated in diseases of protein misfolding and aggregation, including polyglutamine (polyQ) repeat expansion diseases such as Huntington's disease and SBMA. In this review, we discuss the details of the UPS system, its functions and regulation, and the role of AR ubiquitination and UPS components in SBMA. We also discuss aspects of the UPS that may be manipulated for therapeutic effect in SBMA.

Citing Articles

The Role of Mechanotransduction in Contact Inhibition of Locomotion and Proliferation.

Nakamura F Int J Mol Sci. 2024; 25(4).

PMID: 38396812 PMC: 10889191. DOI: 10.3390/ijms25042135.


A phenotypically robust model of spinal and bulbar muscular atrophy in Drosophila.

Richardson K, Sengupta M, Sujkowski A, Libohova K, Harris A, Wessells R J Neurosci Res. 2024; 102(1):e25278.

PMID: 38284836 PMC: 11237963. DOI: 10.1002/jnr.25278.


Regulation of androgen receptor stability by the β Pix/STUB1 complex.

Chahdi A, Jorgez C, Seth A FASEB J. 2024; 38(2):e23408.

PMID: 38197270 PMC: 11832013. DOI: 10.1096/fj.202301100R.


Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.

Blount J, Patel N, Libohova K, Harris A, Tsou W, Sujkowski A J Neurol Sci. 2023; 454:120828.

PMID: 37865002 PMC: 10841544. DOI: 10.1016/j.jns.2023.120828.


Huntingtin-associated protein 1-associated intracellular trafficking in neurodegenerative diseases.

Chen X, He E, Su C, Zeng Y, Xu J Front Aging Neurosci. 2023; 15:1100395.

PMID: 36824265 PMC: 9941194. DOI: 10.3389/fnagi.2023.1100395.

References
1.
Rusilowicz-Jones E, Brazel A, Frigenti F, Urbe S, Clague M . Membrane compartmentalisation of the ubiquitin system. Semin Cell Dev Biol. 2021; 132:171-184. DOI: 10.1016/j.semcdb.2021.11.016. View

2.
Bott L, Badders N, Chen K, Harmison G, Bautista E, Shih C . A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy. Hum Mol Genet. 2016; 25(10):1979-1989. PMC: 5062587. DOI: 10.1093/hmg/ddw073. View

3.
Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, Leguern E . A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab. 2002; 87(8):3893-901. DOI: 10.1210/jcem.87.8.8780. View

4.
Park E, Dezhbord M, Lee A, Kim K . The Roles of Ubiquitination in Pathogenesis of Influenza Virus Infection. Int J Mol Sci. 2022; 23(9). PMC: 9105177. DOI: 10.3390/ijms23094593. View

5.
Lieberman A, Shakkottai V, Albin R . Polyglutamine Repeats in Neurodegenerative Diseases. Annu Rev Pathol. 2018; 14:1-27. PMC: 6387631. DOI: 10.1146/annurev-pathmechdis-012418-012857. View